Blue Trust’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$873K Buy
2,958
+21
+0.7% +$5.53K 0.01% 326
2026
Q2
$666K Buy
2,937
+361
+14% +$64.3K 0.01% 393
2026
Q1
$444K Buy
2,576
+144
+6% +$26.7K 0.01% 515
2025
Q4
$485K Sell
2,432
-343
-12% -$62.2K 0.01% 494
2025
Q3
$434K Buy
2,775
+213
+8% +$33.8K ﹤0.01% 535
2025
Q2
$389K Buy
2,562
+155
+6% +$20.7K ﹤0.01% 539
2025
Q1
$362K Buy
2,407
+904
+60% +$152K ﹤0.01% 505
2024
Q4
$277K Sell
1,503
-374
-20% -$72K ﹤0.01% 549
2024
Q3
$388K Buy
1,877
+418
+29% +$86.9K 0.01% 560
2024
Q2
$395K Buy
1,459
+234
+19% +$53K 0.01% 467
2024
Q1
$332K Buy
1,225
+240
+24% +$57.3K ﹤0.01% 368
2023
Q4
$193K Buy
985
+177
+22% +$34.8K ﹤0.01% 456
2023
Q3
$170K Buy
808
+682
+541% +$140K ﹤0.01% 476
2023
Q2
$26K Sell
126
-1,140
-90% -$227K ﹤0.01% 944
2023
Q1
$276K Buy
1,266
+364
+40% +$82.5K ﹤0.01% 434
2022
Q4
$178K Buy
902
+899
+29,967% +$196K ﹤0.01% 494
2022
Q3
$1K Sell
3
-85
-97% -$18.4K ﹤0.01% 1900
2022
Q2
$25K Buy
+88
New +$21.5K ﹤0.01% 896

Other funds holding CRL

Blue Trust's CRL Position: Q3 2026 in Review

Blue Trust increased its Charles River Laboratories (CRL) stake by 0.72% in Q3 2026, buying an estimated $5.53K and bringing the position to 2,958 shares worth $873K. The position accounts for 0.01% of the portfolio, ranked #326.

Blue Trust first reported a position in CRL in Q2 2022 and has held it in 18 quarters since. 515 funds tracked by Wall St. Rank hold CRL as of Q3 2026.

  • Blue Trust held 2,958 shares of Charles River Laboratories worth $873K as of Q3 2026.
  • Blue Trust bought 21 Charles River Laboratories shares in Q3 2026, an estimated $5.53K.
  • Charles River Laboratories made up 0.01% of Blue Trust's portfolio in Q3 2026, its #326 holding.
  • Blue Trust first reported a position in Charles River Laboratories in Q2 2022 and has held it in 18 quarters since.
  • 515 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2026.

Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.